# OnCo record flutamide (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/flutamide/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "flutamide" ;
  schema:name "Flutamide"@en ;
  schema:description "Flutamide was the first tablet to block testosterone at the prostate cancer cell. It is taken with an injection that stops testosterone production, but newer drugs have largely replaced it."@en ;
  schema:url <https://onco.cc/drugs/flutamide/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Flutamide> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=flutamide>, <https://www.cancer.gov/about-cancer/treatment/drugs/flutamide> ;
  onco:status "approved" ;
  onco:tag "nci-list", "generic" ;
  onco:modality "Non-steroidal antiandrogen (first generation)" ;
  schema:alternateName "Eulexin (historic)" ;
  onco:approval "US 1989: Locally advanced (B2 to C) and metastatic (D2) prostate cancer in combination with an LHRH agonist" ;
  onco:related <https://onco.cc/drugs/bicalutamide/> ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:technologies <https://onco.cc/technologies/androgen-deprivation/> ;
  onco:targets <https://onco.cc/targets/androgen-receptor/> ;
  onco:companies <https://onco.cc/companies/merck/> ;
  onco:trials <https://onco.cc/trials/nct00104741/>, <https://onco.cc/trials/nct00002881/>, <https://onco.cc/trials/nct03678025/> .